Biohaven Ltd. (BHVN) NYSE
10.13
-1.3(-11.37%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
10.13
-1.3(-11.37%)
Currency In USD
Address
215 Church Street
New Haven, CT 06510
United States of America (the)
Phone
203 404 0410
Website
Sector
Healthcare
Industry
Biotechnology
Employees
256
First IPO Date
September 23, 2022
| Name | Title | Pay | Year Born |
| Vladimir Coric | Chairman & Chief Executive Officer | 1.4M | 1971 |
| Kimberly Gentile | Senior Vice President of Clinical Operations | 757,722 | 1966 |
| Bruce D. Car DACVP | Chief Scientific Officer | 801,361 | 1962 |
| Matthew Buten | Chief Financial Officer | 858,610 | 1961 |
| Clifford Bechtold | President, GM of Biohaven Ireland & Chief Compliance Officer | 0 | N/A |
| George C. Clark | Vice President & Chief Accounting Officer | 0 | 1985 |
| John McGill | Chief Technology Officer | 0 | N/A |
| Warren Volles | General Counsel & Chief Legal Officer | 0 | N/A |
| Deb Young | Senior Director of Regulatory Affairs & Operations | 0 | N/A |
| Jennifer Porcelli | Vice President of Investor Relations | 0 | N/A |
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.